Skip to main content
Journal of Experimental Orthopaedics

Table 5 Postoperative Anticoagulation Regimens following THA in HRT Users vs. Control

From: Hormone replacement therapy does not increase thrombosis risk following THA: a national database study

 

HRT

(n = 2104)

Control

(n = 20,485)

OR

95% CI

P

Aspirin

483

22.96%

4431

21.63%

1.08

0.97—1.20

0.1605

Rivaroxaban

400

19.01%

5613

27.40%

0.62

0.56—0.70

 < 0.0001

Apixaban

87

4.13%

795

3.88%

1.07

0.85—1.34

0.5667

Enoxaparin

489

23.24%

4180

20.41%

1.18

1.06—1.31

0.0022

Warfarin

645

30.66%

5466

26.68%

1.21

1.10—1.34

0.0001

  1. Postoperative anticoagulation regimens prescribed within 7 days of primary THA obtained through pharmacy claims data available in the PearlDiver Mariner dataset
Back to article page